CNTA 250117 30.00P (CNTA250117P30000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

CNTA250117P30000

Watchlist

0.00
0.000.00%

15min DelayClose Jan 10 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Is Centessa Pharmaceuticals Plc (CNTA) the Best Growth Stock to Buy Now Under $25?
Yahoo FinanceJan 9 17:14 ET
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and Centessa Pharmaceuticals (CNTA)
TipRanksJan 9 09:10 ET · Ratings
Centessa Pharmaceuticals Updates on OX2R Agonist Pipeline
TipRanksJan 8 07:31 ET
Press Release: Centessa Pharmaceuticals Announces Appointment of Stephen Kanes, MD PhD, as Chief Medical Officer
Dow JonesJan 8 07:05 ET
TD Cowen Initiates Centessa Pharmaceuticals ADR at Buy
MT NewswiresJan 7 08:01 ET
TD Cowen Initiates Centessa Pharmaceuticals(CNTA.US) With Buy Rating
Moomoo NewsJan 7 06:37 ET · Ratings

Comments

Stock_Drift

Sep 26, 2024 05:05

$Centessa Pharmaceuticals (CNTA.US)$

Trytosaveabit

Apr 23, 2024 15:37

Update

$Centessa Pharmaceuticals (CNTA.US)$ Press Release: Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
Dow Jones· 15 mins ago
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for p...

Trytosaveabit

Apr 22, 2024 06:10

Update

$Centessa Pharmaceuticals (CNTA.US)$ The FDA Has Cleared Centessa Pharmaceuticals' Investigational New Drug Application To Initiate A Phase 1 First-in-human, Clinical Trial Of ORX750 For Narcolepsy

Meltyy

Apr 2, 2024 22:13

Gear up for AACR24!

See Biotech companies with cancer assets 👇
⇨ held by 5 biopharma-focused hedge funds! 🔥
$Arcellx (ACLX.US)$ : Anito-cel (Ph 2)
$Adaptimmune Therapeutics (ADAP.US)$ : Afami-cel (PDUFA) ⏳
$Bicycle Therapeutics (BCYC.US)$ : BT8009 (Ph 1/2)
$Centessa Pharmaceuticals (CNTA.US)$ : LB101 (Ph 1/2)
$Day One Biopharmaceuticals (DAWN.US)$ : Tovorafenib (PDUFA) (check comments for details)
$Fate Therapeutics (FATE.US)$ : FT576 (Ph 1)
$Fusion Pharmaceuticals (FUSN.US)$ : FPI-2265 (Ph 2)
$GRCL: ...

JESSE JAMES8832

Feb 10, 2024 10:15

buy

$Centessa Pharmaceuticals (CNTA.US)$